Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells.
Read More…
Industry, Sector and Symbol
Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
Phone631-694-9555
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$38.85 million
Profitability
Miscellaneous
Employees118
Next Earnings Date5/13/2020 (Estimated)
OptionableNot Optionable
Misonix (NASDAQ:MSON) Frequently Asked Questions
What is Misonix's stock symbol?
Misonix trades on the NASDAQ under the ticker symbol "MSON."
How were Misonix's earnings last quarter?
Misonix, Inc. (NASDAQ:MSON) released its earnings results on Wednesday, February, 5th. The medical equipment provider reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.08. The medical equipment provider had revenue of $19.72 million for the quarter. Misonix had a negative return on equity of 7.80% and a negative net margin of 14.40%. View Misonix's Earnings History.
When is Misonix's next earnings date?
What guidance has Misonix issued on next quarter's earnings?
Misonix updated its FY 2020
After-Hours earnings guidance on Wednesday, February, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $46.618 million, compared to the consensus revenue estimate of $73.25 million.
What price target have analysts set for MSON?
2 equities research analysts have issued 1-year target prices for Misonix's stock. Their forecasts range from $27.00 to $30.00. On average, they expect Misonix's stock price to reach $28.50 in the next twelve months. This suggests a possible upside of 70.7% from the stock's current price. View Analyst Price Targets for Misonix.
What is the consensus analysts' recommendation for Misonix?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Misonix.
Has Misonix been receiving favorable news coverage?
News stories about MSON stock have trended negative on Sunday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Misonix earned a news sentiment score of -2.4 on InfoTrie's scale. They also assigned news headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Misonix.
Who are some of Misonix's key competitors?
Some companies that are related to Misonix include Oxford Instruments (OXINF), Aixtron (AIXA), iSignthis (ISX), ePlus (PLUS), TiVo (TIVO), Pushpay (PPH), Talend (TLND), Stratasys (SSYS), Model N (MODN), Dicker Data (DDR), Unisys (UIS), QAD (QADA), Isra Vision (ISR), Radware (RDWR) and FARO Technologies (FARO).
What other stocks do shareholders of Misonix own?
Who are Misonix's key executives?
Misonix's management team includes the folowing people:
- Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
- Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
- Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
- Ms. Sharon W. Klugewicz, Chief Operating Officer (Age 51)
- Mr. John J. Salerno, VP of Quality and Regulatory Affairs & Chief Compliance Officer (Age 64)
Who are Misonix's major shareholders?
Misonix's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Parkman Healthcare Partners LLC (1.22%), Renaissance Technologies LLC (0.82%), Geode Capital Management LLC (0.81%), State Street Corp (0.86%), Essex Investment Management Co. LLC (0.56%) and Ingalls & Snyder LLC (0.31%). Company insiders that own Misonix stock include Christopher H Wright, Joseph J Brennan, Joseph P Dwyer and Sharon W Klugewicz. View Institutional Ownership Trends for Misonix.
Which institutional investors are selling Misonix stock?
MSON stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Martingale Asset Management L P, Acadian Asset Management LLC, Bessemer Group Inc. and Ingalls & Snyder LLC. View Insider Buying and Selling for Misonix.
Which institutional investors are buying Misonix stock?
MSON stock was acquired by a variety of institutional investors in the last quarter, including Parkman Healthcare Partners LLC, State Street Corp, Geode Capital Management LLC, Bank of Montreal Can, Tiedemann Advisors LLC, DAVENPORT & Co LLC, Bank of America Corp DE and Charles Schwab Investment Management Inc.. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer and Sharon W Klugewicz. View Insider Buying and Selling for Misonix.
How do I buy shares of Misonix?
Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Misonix's stock price today?
One share of MSON stock can currently be purchased for approximately $16.70.
How big of a company is Misonix?
What is Misonix's official website?
How can I contact Misonix?
Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.
MarketBeat Community Rating for Misonix (NASDAQ MSON)
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
